Potentiation of 5-fluorouracil induced inhibition of thymidylate synthase in human colon tumors by leucovorin is dose dependent. 1993

G J Peters, and K Hoekman, and C J van Groeningen, and C L van der Wilt, and K Smid, and S Meijer, and H M Pinedo
Dept. Oncology, Free University Hospital, Amsterdam, The Netherlands.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005468 Fluorodeoxyuridylate 5-Fluoro-2'-deoxyuridylate. An inhibitor of thymidylate synthetase. Formed from 5-fluorouracil or 5-fluorodeoxyuridine. 5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,FdUMP,5 Fluoro 2' Deoxyuridine 5' Monophosphate
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013940 Thymidylate Synthase An enzyme of the transferase class that catalyzes the reaction 5,10-methylenetetrahydrofolate and dUMP to dihydrofolate and dTMP in the synthesis of thymidine triphosphate. (From Dorland, 27th ed) EC 2.1.1.45. Thymidylate Synthetase,Synthase, Thymidylate,Synthetase, Thymidylate

Related Publications

G J Peters, and K Hoekman, and C J van Groeningen, and C L van der Wilt, and K Smid, and S Meijer, and H M Pinedo
January 1991, Advances in experimental medicine and biology,
G J Peters, and K Hoekman, and C J van Groeningen, and C L van der Wilt, and K Smid, and S Meijer, and H M Pinedo
September 1992, Cancer research,
G J Peters, and K Hoekman, and C J van Groeningen, and C L van der Wilt, and K Smid, and S Meijer, and H M Pinedo
July 1990, Cancer research,
G J Peters, and K Hoekman, and C J van Groeningen, and C L van der Wilt, and K Smid, and S Meijer, and H M Pinedo
December 1992, Cancer,
G J Peters, and K Hoekman, and C J van Groeningen, and C L van der Wilt, and K Smid, and S Meijer, and H M Pinedo
January 1989, Advances in experimental medicine and biology,
G J Peters, and K Hoekman, and C J van Groeningen, and C L van der Wilt, and K Smid, and S Meijer, and H M Pinedo
January 1993, Anticancer research,
G J Peters, and K Hoekman, and C J van Groeningen, and C L van der Wilt, and K Smid, and S Meijer, and H M Pinedo
January 1988, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
G J Peters, and K Hoekman, and C J van Groeningen, and C L van der Wilt, and K Smid, and S Meijer, and H M Pinedo
January 2014, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,
G J Peters, and K Hoekman, and C J van Groeningen, and C L van der Wilt, and K Smid, and S Meijer, and H M Pinedo
October 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
G J Peters, and K Hoekman, and C J van Groeningen, and C L van der Wilt, and K Smid, and S Meijer, and H M Pinedo
January 1995, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!